Jan

    Navigating the Intersection of Foreign Investment Review and Merger Review

    12 PM EST

    Getting cross-border deals done in a complex regulatory environment where antitrust merger review frequently intersects with foreign investment and sectoral review has become more challenging.  High profile deals such as GE/Alstom, Pfizer/AstraZeneca, ADM/GrainCorp and Ralls/Sany illustrate the relevance of this issue. This program features a former CFIUS official, who will provide an inside perspective into the CFIUS process, as well as speakers from the private sector with significant foreign investment review experience in the US, UK and EU.  Panelists will also provide practical tips for efficiently achieving foreign investment review approvals.

    Moderator
    *Michael Keeley, Axinn Veltrop & Harkrider LLP

    Panelists
    *Timothy R.W. Cowen, Sidley Austin LLP
    *Anne W. Salladin, Stroock & Stroock & Lavan LLP
    *William R. Vigdor, Vinson & Elkins LLP

     

    FREE:  Antitrust Section Members, Government, Nonprofit Emmployees and Students.
    $25.00:  Other Non-members.

    Learn about Section membership or call 800-285-2221 to join with source code:  RAT14IP25.  Instructions for accessing the live program will be provided in a confirmation email.  For this and all upcoming events visit:  http://AmBar.org/ATEvents.

    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive
    Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

     


     

    $25
    NON-MEMBERS
    $10
    MEMBERS
    $0
    SECTION MEMBERS
    Register Now *Additional discounts may apply at checkout

    Log In to view your rate

    Navigating the Intersection of Foreign Investment Review and Merger Review

    Event Details

    Format

    Teleconference

    Date

    Jan 21, 2015

    2015-01-21T12:00:00-05:00 2015-01-21T13:00:00-05:00 Navigating the Intersection of Foreign Investment Review and Merger Review

    Getting cross-border deals done in a complex regulatory environment where antitrust merger review frequently intersects with foreign investment and sectoral review has become more challenging.  High profile deals such as GE/Alstom, Pfizer/AstraZeneca, ADM/GrainCorp and Ralls/Sany illustrate the relevance of this issue. This program features a former CFIUS official, who will provide an inside perspective into the CFIUS process, as well as speakers from the private sector with significant foreign investment review experience in the US, UK and EU.  Panelists will also provide practical tips for efficiently achieving foreign investment review approvals.

    Moderator
    *Michael Keeley, Axinn Veltrop & Harkrider LLP

    Panelists
    *Timothy R.W. Cowen, Sidley Austin LLP
    *Anne W. Salladin, Stroock & Stroock & Lavan LLP
    *William R. Vigdor, Vinson & Elkins LLP

     

    FREE:  Antitrust Section Members, Government, Nonprofit Emmployees and Students.
    $25.00:  Other Non-members.

    Learn about Section membership or call 800-285-2221 to join with source code:  RAT14IP25.  Instructions for accessing the live program will be provided in a confirmation email.  For this and all upcoming events visit:  http://AmBar.org/ATEvents.

    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive
    Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

     


     

    Sponsors

    Section of Antitrust Law

    Related Products

    Related On-Demand CLE